prop-2-yn-1-yl 3-methylbutanoate | 1289157-09-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: prop-2-yn-1-yl 3-methylbutanoate
• 英文别名: 2-propynyl 3-methylbutanoate；prop-2-ynyl 3-methylbutanoate
• CAS: 1289157-09-0
• 化学式: C₈H₁₂O₂
• 分子量: 140.182
• InChiKey: NGIACXPCQQNGKP-UHFFFAOYSA-N

物化性质

• 沸点：
  184.3±13.0 °C(Predicted)
• 密度：
  0.945±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  二哌啶甲烷 、 prop-2-yn-1-yl 3-methylbutanoate 在 copper(l) chloride 作用下， 反应 6.0h， 以54%的产率得到4-piperidinobut-2-yn-1-yl 3-methylbutanoate
  参考文献：
  名称：

  Aminomethylation of acetylene alcohols and their esters with gem-diamines catalyzed by complexes of d-transition and rare-earth metals

  摘要：

  An efficient synthetic procedure was developed for preparation of oxygen-containing propargylamines with high yields and selectivity by aminomethylation of propargyl alcohols and their esters with gem-diamines catalyzed by complexes and salts of d-transition metals and lanthanides.

  DOI：

  10.1134/s1070428011020023
• 作为产物：
  描述：

  2-丙炔-1-醇 、 异戊酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 5.25h， 以83%的产率得到prop-2-yn-1-yl 3-methylbutanoate
  参考文献：
  名称：

  环丙基氨基醇基锌催化剂催化炔基酯和醚对醛的对映选择性加成

  摘要：

  通过在环丙氨基醇基锌催化剂的促进下将炔基酯或醚不对称加成到醛上，开发了一种新型的、高度对映选择性的羟基炔基酯和醚的合成方法。该方法提供了一个新的对映体富集的羟基炔醇酯和醚的库（产率高达 93%；95% ee），并且它与广泛的官能团兼容。此外，它还可以用于合成碳链延长的对映体富集的羟基炔醇酯和 (2R,5R)-musclide-A1，这是一种来自麝香的强心剂。

  DOI：

  10.1055/s-0039-1690264

文献信息

• POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT
  申请人：POLYACTIVA PTY LTD

  公开号：US20160000929A1

  公开（公告）日：2016-01-07

  The presentinvention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety selected from prostaglandin analogues, β-blockers and mixtures thereof. The present invention also relates to methods for preparing the polymer conjugates using click chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the treatment of glaucoma.

  本发明通常涉及聚合物-生物活性剂共轭物，用于将生物活性剂传递给对象。聚合物-生物活性剂共轭物在聚合物骨架中含有三唑基团和从前列腺素类似物、β受体阻滞剂和其混合物中选择的生物活性基团。本发明还涉及使用点击化学反应制备聚合物共轭物的方法，适用于制备聚合物共轭物的单体-生物活性剂共轭物，以及包含聚合物共轭物的制药产品，用于治疗青光眼。
• Novel inhibitors of Hepatitis C virus NS3 protease
  申请人：Bogen L. Stephane

  公开号：US20070142301A1

  公开（公告）日：2007-06-21

  The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
• NOVEL COMPOUND HAVING BLT INHIBITORY ACTIVITY AND COMPOSITION, FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, COMPRISING SAME AS ACTIVE INGREDIENT
  申请人：DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

  公开号：US20180215706A1

  公开（公告）日：2018-08-02

  The present invention relates to a novel compound showing leukotriene B4 receptor 2 (BLT2) inhibitory activity and a pharmaceutical composition, for preventing or treating inflammatory diseases, having same as an active ingredient. The inventors identified a novel compound containing BTL2 inhibitory activity, and experimentally confirmed that the present novel compound had an excellent effect on the enhancement of the cancer cell death, on the inhibition of the metastasis and chemotactic mobility, and on the anti-asthma activity. Therefore, the present novel compound can be used as a very effective pharmaceutical component for treating the inflammatory-related diseases.
• US7205330B2
  申请人：——

  公开号：US7205330B2

  公开（公告）日：2007-04-17
• US7423058B2
  申请人：——

  公开号：US7423058B2

  公开（公告）日：2008-09-09